Dolores J. Schendel
Papers
1
Total Citations
30
H-Index
1
About
Dolores J. Schendel is a pioneering immunologist whose work has fundamentally advanced the field of cancer immunotherapy, with a particular focus on dendritic cell (DC) vaccines and T-cell biology. Her major contributions lie in developing personalized cellular therapies that harness the patient's own immune system to combat tumors. A landmark achievement is her leadership of a long-term, first-in-man Phase I/II study of an adjuvant dendritic cell vaccine for patients with high-risk prostate cancer after radical prostatectomy. This work, published in 2021 and garnering over 30 citations, demonstrated the feasibility and safety of a personalized DC vaccine in reducing the risk of biochemical relapse, a critical step toward noncurative disease. Schendel's research has been instrumental in translating complex immunological principles into clinical applications, establishing benchmarks for cellular vaccine design and efficacy. Her notable achievements include pioneering the use of patient-specific tumor antigens to prime dendritic cells, thereby enhancing targeted immune responses. With a career spanning decades, Schendel's impact is evident in the foundational knowledge she has provided for subsequent immunotherapies, making her a key figure in the quest to turn cancer into a manageable disease.
Research Focus
Key Achievements
Top Papers
- 1